Rudolf Baumgartner
Direttore Tecnico/Scientifico/R&S presso SANA AB
Provenienza dei contatti di primo grado di Rudolf Baumgartner
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
19
| Public Company | Biotechnology | 19 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Rudolf Baumgartner tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Saniona A/S
 Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| NTG NORDIC TRANSPORT GROUP A/S | Trucking | Founder Director of Finance/CFO Corporate Officer/Principal Director/Board Member Director/Board Member | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Aniona ApS
 Aniona ApS Medical/Nursing ServicesHealth Services Aniona ApS is a private company based in Ballerup, Denmark. Jørgen Drejer has been the CEOs since incorporation. The Danish company was founded by Thomas Feldthus, Anker Gunvald Lundemose, Claus Tycho Bræstrup, Jørgen Drejer. | Medical/Nursing Services | Founder Founder | |
| Stockholm School of Economics | College/University | Graduate Degree | |
| ONCOZENGE AB | Pharmaceuticals: Major | Chairman | |
| ADDVISE GROUP AB | Medical Distributors | Director/Board Member | |
| Moberg Derma Incentives AB | Chairman | ||
Mpj Otc AB
 Mpj Otc AB Pharmaceuticals: OtherHealth Technology Part of Moberg Pharma AB, Mpj Otc AB is a company that manufactures and distributes therapeutic medicines and personal products. | Pharmaceuticals: Other | Director/Board Member | |
Advantice Health LLC (New Jersey)
 Advantice Health LLC (New Jersey) Medical DistributorsDistribution Services Advantice Health LLC manufactures and supplies therapeutic medicines and personal products. It is engaged in the marketing, sale and distribution of over-the-counter (OTC) medicines to drug stores, food stores, mass merchandisers, health professionals and international markets. It is best known for podiatrist recommended Kerasal One-Step Exfoliating Moisturizer Therapy. The company was founded in 2004 and is headquartered in Cedar Knolls, NJ. | Medical Distributors | Director/Board Member | |
| Boston College | College/University | Undergraduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Comptroller/Controller/Auditor | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director of Finance/CFO | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
New England Baptist Hospital
 New England Baptist Hospital Hospital/Nursing ManagementHealth Services New England Baptist Hospital provides orthopedic surgery and the treatment of musculoskeletal diseases and disorders. Its services include orthopedics, general surgery, medical services, patient care services, and programs. The company was founded by Francis Fremont Whittier in 1893 and is headquartered in Boston, MA. | Hospital/Nursing Management | Director/Board Member | |
| ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Deloitte LLP (New York)
 Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Lipopetide AB | Director of Finance/CFO | ||
| MOBERG PHARMA AB | Pharmaceuticals: Major | Chief Executive Officer | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
Cheminova A/S
 Cheminova A/S Chemicals: AgriculturalProcess Industries Cheminova A/S manufactures pesticides and other agrochemical products. It offers herbicides, insecticides, fungicides, seed dressings, regulants, grain protectants, and animal health products. The company was founded by Gunnar Andreasen in 1938 and is headquartered in Harboøre, Denma rk. | Chemicals: Agricultural | Corporate Officer/Principal | |
| Network of Tyrosinemia Advocates, Inc. | Director/Board Member | ||
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Human Resources Officer | |
| Tulane University (Louisiana) | College/University | Undergraduate Degree | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Founder | |
| London Business School | College/University | Masters Business Admin | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Director of Finance/CFO | |
| Fertilizer Invest ApS | Chief Executive Officer | ||
Leukotech A/S
 Leukotech A/S Pharmaceuticals: MajorHealth Technology Leukotech A/S develops and manufactures pharmaceutical products. It develops agents for prevention and treatment of life-threatening infections and severe inflammatory disorders. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Founder | |
| SCANDION ONCOLOGY A/S | Pharmaceuticals: Major | Founder | |
ResoTher Pharma AS
 ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | Pharmaceuticals: Major | Director/Board Member | |
| INITIATOR PHARMA A/S | Pharmaceuticals: Major | Founder | |
Rehaler ApS
 Rehaler ApS Medical SpecialtiesHealth Technology Rehaler ApS develops medical devices for the treatment of migraine. | Medical Specialties | Chairman | |
Synklino A/S
 Synklino A/S BiotechnologyHealth Technology Synklino A/S develops a CMV-specific immunotoxin that aims to eliminate cytomegalovirus infections. | Biotechnology | Director/Board Member | |
| University of London | College/University | Graduate Degree | |
| Technical University of Denmark | College/University | Graduate Degree | |
| CANDEL THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| St. Bonaventure University | College/University | Undergraduate Degree | |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Biotechnology | Public Communications Contact | |
| ABBVIE INC. | Pharmaceuticals: Major | General Counsel | |
Lumanity, Inc. (United States)
 Lumanity, Inc. (United States) Data Processing ServicesTechnology Services Part of Lumanity, Inc., the company is a data analytics firm based in Bethesda, MD. The company specializes in transforming data into real-world insights and evidence to power successful commercialization and empower stakeholders to take timely and decisive action. Jon Williams has been the CEO of the company since 2022. | Data Processing Services | Corporate Officer/Principal | |
| NURIX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | General Counsel |
Statistiche
Distribuzione geografica
| Stati Uniti | 23 |
| Danimarca | 19 |
| Svezia | 9 |
| Regno Unito | 3 |
Settori
| Health Technology | 28 |
| Consumer Services | 9 |
| Commercial Services | 3 |
| Health Services | 3 |
| Distribution Services | 3 |
Posizioni
| Director/Board Member | 91 |
| Corporate Officer/Principal | 34 |
| Independent Dir/Board Member | 25 |
| Director of Finance/CFO | 19 |
| Founder | 16 |
Contatti più connessi
| Insiders | |
|---|---|
| Joseph deBethizy | 29 |
| Jørgen Drejer | 26 |
| Robert Hoffman | 22 |
| Carl Johan Bertil Sundberg | 21 |
| Thomas Feldthus | 20 |
| Anna Ljung | 11 |
| Jason Amello | 11 |
| Denelle Waynick | 11 |
| Wendy Dwyer | 8 |
| Edward Saltzman | 7 |
| Rami Levin | 7 |
| Trista Morrison | 6 |
| Linea Aspesi | 6 |
| Pierandrea Muglia | 6 |
| Palle Christophersen | 4 |
- Borsa valori
- Insiders
- Rudolf Baumgartner
- Connessioni Società
